Delve into the Amarin v. Hikma case in which the U.S. Supreme Court might settle the skinny label question once and for all.

Discover how AI is transforming biologics discovery, tackling adoption challenges, and driving growth in the biologics market.

Discover J&J’s pipeline strategy for 2026 as it it projects that its sales for the year will be between $100 billion and $101 ...

UK biotech showed resilience in a tough 2025 for healthcare funding, suggesting investor interest could grow in 2026.

Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi ...